🇺🇸 S-1 in United States

126 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 16 reports (12.7%)
  2. Decreased Appetite — 15 reports (11.9%)
  3. Fatigue — 15 reports (11.9%)
  4. Neutropenia — 15 reports (11.9%)
  5. Nausea — 13 reports (10.32%)
  6. Anaemia — 12 reports (9.52%)
  7. Leukopenia — 11 reports (8.73%)
  8. Stomatitis — 10 reports (7.94%)
  9. Thrombocytopenia — 10 reports (7.94%)
  10. Pyrexia — 9 reports (7.14%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is S-1 approved in United States?

S-1 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for S-1 in United States?

TTY Biopharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.